Minimize Uncertainty – Make Informed Decisions – Succeed

Immunology

Immunology Weekly News - September 17th 2025

September 17, 2025IBD,Immunology News,rheumatoid arthritis,biotech,Johnson & Johnson,biosimilars,Sun Pharma,biologics,Monte Rosa Therapeutics,Amgen,Odyssey Therapeutics,drug development,GLP-1 RA,semaglutide,molecular glue degrader,abbvie,Rinvoq,novartis,upadacitinib,sanofi,axial spondyloarthritis,Atopic Dermatitis,IL-23 receptor,Sandoz,OX40,BioPharma and Tech News,TL1A,psoriatic arthritis,pharmaceutical companyTirzepatide,arthritis therapy

🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…

by LucidQuest

EADV 2025_Preview_by_LucidQuest

EADV 2025 Preview: Dermatology and Venereology Highlights to Watch

September 17, 2025prurigo,urticaria,Our Insights,AI in dermatology,Atopic Dermatitis,dermatology,psoriasis,psoriatic arthritis,Alopecia Areata,hidradenitis suppurativa,Skin cancer,Vitiligo,Conference Previews,EADV 2025,acnerosacea,pigmentation

EADV 2025 at a Glance Ahead of EADV 2025, LucidQuest highlights…

by LucidQuest

Women's_Health

Women's Health Weekly News - September 17th 2025

September 17, 2025fda approval,AI in healthcare,BioPharma and Tech News,Medical Research,menopause,IVF,Contraception,InfertilityIndia Health,Women's Health News

Women’s Health Update: Pill Myths, Menopause Program, US Contraceptives,…

by LucidQuest

Prostate drugs AI searches

Advanced Prostate Cancer ARPIs: Efficacy, Safety, and Market Sentiment in an AI-Driven Search World

September 16, 2025mHSPC,nmCRPC,Case studies,ADT,AI in healthcare,Docetaxel triplet,prostate cancer,Overall survival,real-world evidence,Radiographic progression-free survival,Strategic Intelligence,Erleada vs Xtandi vs Nubeqa,Tactical Intelligence,Biopharma Marketing,Androgen receptor inhibitors,Erleada,Apalutamide,Xtandi,Enzalutamide,NubeqaDarolutamide

As AI reshapes how people discover health information, knowing how models…

by Timos Papagatsias

Obesity Weekly News

Obesity Weekly News - September 16th 2025

September 16, 2025Child Obesity,AI Health,wegovy,Obesity News,semaglutide,BioPharma and Tech News,Novo Nordisk,Mounjaro,Tirzepatide,Eli Lilly,Ozempic,Orforglipron,Ascletis,GLP-1 receptor agonist,Oral SemaglutideFangzhou Inc,Innovent Biologics

Obesity Update: ASC30’s Ultra-Long Dosing, Oral GLP-1 Pill Race, Korea…

by LucidQuest

Endocrinology

Endocrinology Weekly Update - September 16th 2025

September 16, 2025Obstructive Sleep Apnea,Hanmi Pharmaceutical,BioPharma and Tech News,Endocrinology News,type 2 diabetes,Gestational Diabetes Mellitus,Exosomes,MicroRNAs,Insulin Initiation,Mortality,Thyroid Artery Embolization,DHEA-S,Adrenal Insufficiency,Osteoporosis Screening,SmokingBRAF Mutations,Nocturnal Hypoglycemia

Endocrinology Update – September 16, 2025: Gestational Diabetes Review,…

by LucidQuest

EASD 2025 Preview: Key Diabetes Highlihts to Watch

September 16, 2025incretins,dual agonists,Our Insights,diabetes technology,machine learning,cardiometabolic,precision medicine,AI in diabetes,obesity,GLP-1,T2D,T1D,CGM,LucidQuest,amylin,GIP,Conference PreviewsEASD 2025,EASD25

EASD 2025 at a glance In the lead-up to EASD 2025, LucidQuest spotlights…

by LucidQuest

Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - September 15th 2025

September 15, 2025Lunit INSIGHT,Strive Health,digital health,NHS AI Imaging,AI in healthcare,Lila Sciences,BioPharma and Tech News,AI in Healthcare and Digital Health,Apple Watch,Eli Lilly,Hypertension Alerts,Eko Health,AI Stethoscope,Philips,Masimo,GE HealthCare,FDA Digital Health AdvisoryAMA CPT 2026,Samsung Medical Center

AI in Healthcare and Digital Health Update: Lung cancer relapse AI, Breast AI…

by Timos Papagatsias

Hematology

Hematology Weekly News - September 15th 2025

September 15, 2025Annamycin,Karyopharm,Multiple Myeloma,Selinexor,Hemophilia A,Hemlibra,BioPharma and Tech News,Emicizumab,AML,myelofibrosis,CLL,Hematology News,Eli Lilly,MDS,SLL,CellCentric,Inobrodib,Jaypirca,PirtobrutinibBiosplice,Cirtuvivint

Hematology Update: Jaypirca CLL win, BTK degrader data, WHO EML update and…

by LucidQuest

Onco_background

Oncology Weekly News - September 15th 2025

September 15, 2025VEGF-A,ENHERTU,BioNTech,Oncology News,BioPharma and Tech News,Ovarian Cancer,HER2,NSCLC,TNBC,BioAtla,Ozuriftamab vedotin,ROR2-ADC,OPSCC,Regeneron,LibtayoCemiplimab,PD-L1

Oncology Update : Ozuriftamab Phase 3, Libtayo 5-Year Data, INLEXZO Approval…

by LucidQuest

Public_Health

Public Health Weekly News - September 12th 2025

September 12, 2025Alzheimer's Disease,childhood obesity,prostate cancer,BioPharma and Tech News,lung cancer,UNICEF,Ultra-processed foods,Chronic disease mortality,IVF,p-tau217,NRF2,Preterm birthMediterranean diet,Public Health News

Public Health Updates: Childhood Obesity, Chronic Disease Trends, And Cannabis…

by LucidQuest

Vaccines

Vaccines Weekly Update - September 12th 2025

September 12, 2025KP.2,Vaccine news,mNexspike,gsk,Spikevax,pfizer,mResvia,Moderna,Lipid nanoparticles,BioNTech,Patent litigation,BioPharma and Tech News,Prefusion F,Colorectal Cancer,Observational analysis,melanoma,Valneva,Glioblastoma,Lyme vaccine,RSV Vaccine,Phase 3,EnteroMix,Alzinova,FMBA Russia,ALZ-101,mRNA cancer vaccine,Amyloid-beta oligomers,COMIRNATY,INDLP.8.1,Early Alzheimer’s

🧬 This Week in Vaccine Research: Cancer, COVID-19, RSV, Lyme Disease &…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.